Efficiency of Trekrezan in experimental bronchopneumonia in rats
Animal research · 2006
- What was studied
- Rats with experimental acute bronchopneumonia
- Main finding
- The abstract reports altered lymphocyte immune measures, lower lactate and higher ATP and pyruvate in lung tissue and blood lymphocytes.
Reported findings and study design
Rat acute-bronchopneumonia model; Trekrezan 25 mg/kg.
Population or model Rats with experimental acute bronchopneumonia
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Lactate/ADP/AMP | Lower values reported | |
| Pyruvate/ATP | Higher values reported | No numerical concentrations supplied |
Values describe this study and its comparison. Unreported effect sizes and missing denominators have not been inferred.
Source for these results ↗ · Reviewed 2026-10-29
Study limitations and source details
Study limitations
- Preclinical disease model; no human pneumonia benefit established. Program overlap with later dissertation and review is possible.
Source details
Citation and available abstract or selected source passages checked; complete methods and risk-of-bias appraisal pending.
Sources checked
Citation
I. V. Zarubina, A. V. Bolekhan, P. D. Shabanov. Efficiency of Trekrezan in experimental bronchopneumonia in rats Bull Exp Biol Med 142(2):205–208
Study source ↗ · DOI 10.1007/s10517-006-0328-4 · Bibliography entry · Link to this summary